Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG

Background: The investigation of the antibody response to SARS-CoV-2 represents a key aspect in facing the COVID-19 pandemic. In the present study, we compared the new Immundiagnostik IDK® anti-SARS-CoV-2 S1 IgG assay with four widely-used commercial serological assays for the detection of antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberhardt, Kirsten Alexandra, Dewald, Felix, Heger, Eva, Gieselmann, Lutz, Vanshylla, Kanika, Wirtz, Maike, Kleipass, Franziska, Johannis, Wibke, Schommers, Philipp, Gruell, Henning, Brensing, Karl August, Müller, Roman-Ulrich, Augustin, Max, Lehmann, Clara, Koch, Manuel, Klein, Florian, Di Cristanziano, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067155/
https://www.ncbi.nlm.nih.gov/pubmed/33807490
http://dx.doi.org/10.3390/microorganisms9040733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067155/
https://www.ncbi.nlm.nih.gov/pubmed/33807490
http://dx.doi.org/10.3390/microorganisms9040733

Ejemplares similares